MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Tuesday, September 24, 2019

1:45pm-3:15pm
A cortical signature of motor response to dopaminergic therapy in Parkinson’s disease

J. Baarbé, K. Lizarraga, J. Saravanamuttu, U. Saha, R. Chen (Toronto, ON, Canada)

Neurophysiology  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
A First in Human Study of PBT434, a Novel Small Molecule Inhibitor of Alpha-Synuclein Aggregation

D. Stamler, M. Bradbury, C. Wong, E. Offman (Newark, CA, USA)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
A flowchart algorithm for the neurologist to discuss and attend sexual issues in Parkinson’s disease

G. Bronner, S. Hassin-Baer, AD. Korczyn, T. Gurevich (Ramat-Gan, Israel)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
A general impaired-rhythm system underpins oro-motor, manual, and gait rhythmic disturbances in Parkinson’s disease

F. Puyjarinet, V. Bégel, C. Gény, V. de Cock, V. Driss, M. Cuartero, S. Pinto, S. Dalla Bella (Montpellier, France)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
A genome wide pleiotropic approach to identify the genetic architecture of multiple system atrophy and its interaction with Parkinson’s disease

A. Ashokkumar Sreelatha, A. Shadrin, C. Blauwendraat, O. Frei, T. Gasser, G. Wenning, A. Singleton, H. Houlden, S. Scholz, O. Andreassen, M. Sharma (Tübingen, Germany)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
A hexanucleotide repeat within a SINE-VNTR-Alu retrotransposon inserted in TAF1 modifies expressivity of X-linked dystonia-parkinsonism

A. Westenberger, C. Reyes, G. Saranza, V. Dobricic, H. Hanssen, A. Domingo, B-H. Laabs, A. Rakovic, P. Bauer, A. Rolfs, A. Münchau, L. Ozelius, R.. Jamora, R. Rosales, C. Diesta, K. Lohmann, I. König, N. Brüggemann, C. Klein (Kalakhang Maynila, Philippines)

Dystonia  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
A Lewy body disease of widely confirmed Lewy bodies in the cerebral cortexes including the occipital lobe without pathological changes in the hippocampal CA2/3 region

M. Ryo, K. Hasegawa, I. Saitoh, S. Yagishita (Tokyo, Japan)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
A Neuroscientific approach for MCI Characterization using a Motor and Cognitive Dual-Task

G. Mancioppi, F. Fiorini, M. Timpano Sportiello, E. Rovini, F. Cavallo (Pontedera, Italy)

Classification of Movement Disorders  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
A novel heterozygous ANO3 mutation responsible for myoclonus-dystonia

C. Laurencin, E. Broussolle, T. Danaila, M. Anheim, J. Chelly, S. Thobois (Lyon, France)

Dystonia  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
A novel intermittent control paradigm to investigate oscillatory neuronal activity in the STN

M. Boca, N. Ray, C. Kobylecki, J. Evans, I. Loram, M. Silverdale (Manchester, United Kingdom)

Neurophysiology  ·  Les Muses Terrace, Level 3